Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inflammatory cytokine expression in Fabry disease: impact of disease phenotype and alterations under enzyme replacement therapy.

Frontiers in immunology - 1 Jan 2024

Yuan Yujing, Zhao Yawen, Li Fan, Ling Chen, Wu Yuan, Ma Wei, Wang Zhaoxia, Yuan Yun, Hao Hongjun, Zhang Wei

Abstract excerpt

Objectives: The aim of this study is to explore the expression of inflammatory cytokines (ICs) in Fabry disease (FD), the correlation between ICs and FD phenotypes, and the impact of enzyme replacement therapy (ERT) on IC expression. Methods: We recruited 67 FD patients and 44 healthy controls (HCs) and detected concentrations of the following ICs: interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Galactosidase
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Enzyme Replacement Therapy

Share to Fabry Disease

Share to Inflammation

Share to Inflammation Mediators

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 39234251
DOI: 10.3389/fimmu.2024.1367252
PMCID: PMC11371600

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inflammatory cytokine expression in Fabry disease: impact of disease phenotype and alterations under enzyme replacement therapy.PMID 39234251Read ↗

An association study of inflammatory cytokine gene polymorphisms in Fabry disease.Semantic proximity Read ↗

Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease.Semantic proximity Read ↗

Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry DiseaseSemantic proximity Read ↗

Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry diseaseSemantic proximity Read ↗

Inflammation and Exosomes in Fabry Disease PathogenesisSemantic proximity Read ↗

Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.Semantic proximity Read ↗

Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive ReviewSemantic proximity Read ↗

A validated disease severity scoring system for Fabry disease.Semantic proximity Read ↗

Cytokine overproduction in healthy first degree relatives of patients with IDDMSemantic proximity Read ↗

Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.Semantic proximity Read ↗

Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter study.Semantic proximity Read ↗

Mitochondrial stress markers associate with phenotypic variability in Fabry diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.